EKOS Corporation provides a system for the treatment of vascular thrombosis.
EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2006 | Series C | $26M | 1 | — | — | Detail |
Feb 18, 2005 | Series B | $18M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
EGS Healthcare Capital Partners | — | Series C |